-
Agile Manufacturing Partner
Providing products and manufacturing services for advanced therapies since 2006
-
Services
Plasmid DNA
At Akron, we manufacture high-quality compliant cGMP plasmid DNA for pre-clinical, clinical, and commercial gene therapy and vaccine companies.
Protein & Nuclease Development
Akron offers comprehensive recombinant protein and nuclease development and manufacturing under cGMP compliance. Our approach to developing novel cytokines and gene editing tools is to establish a strong foundation through extensive investigation and optimization, enabling a seamless transition to large-scale production.
Custom Media & Protein Services
Capitalizing on our established platform for manufacturing cGMP-compliant, clinical-grade ancillary products, Akron is well-positioned to provide custom development and manufacturing to accelerate the commercialization of advanced therapies.
Transfection & Transduction Reagents
We offer cGMP-compliant viral transduction enhancers and non-viral transfection reagents and solutions to enable your therapeutic programs’ success. We offer flexible filling capabilities and several manufacturing environments to meet your needs.
Products
Cytokines & Growth Factors
Akron’s high-quality cGMP Recombinant Proteins offer the consistency, safety, and efficacy that empower today’s leading clinical and commercial cell therapy companies.
Human Plasma Derived Products
Akron’s proven blood products deliver safety and performance backed by robust and redundant supply. Because you can’t afford to compromise.
Media & Media Supplements
We offer critical media and media supplements in both cGMP and high-quality research grade.
Closed System Solutions™ (CSS)
Our CSS product line is available in single-use, ready-to-use bags with weldable tubing to ensure consistency and sterility. This product line was developed to integrate optimally dosed, cGMP-compliant blood-derived products and liquid cytokines across manufacturing platforms.
Latest News Annoucement
Jan 17, 2023
Akron Bio Receives Eligibility Confirmation from PMDA in Japan for the Commercialization of Virus Inactivated Human Fibronectin in Clinical Cell Therapy Manufacturing
Read MoreRecent News
See more in NewsroomUpcoming Events
November 28 - 30, 2023
CRISPR 2.0
Boston, MA
Stop by our booth at this year's CRISPR 2.0 event or reach out to one of our team members to learn about our Endonuclease development and manufacturing services. We hope to see you there!
December 4 - 6, 2023
Cell & Gene Therapy Manufacturing & Commercialization Congress - Europe
Dublin, Ireland
Join members of our team at this year's Cell & Gene Therapy Manufacturing & Commercialization Congress in Dublin! Connect with our team to learn about our product and service offerings.
January 16 - 19, 2024
Advanced Therapies Week
Miami Beach, FL
Our team is kicking off 2024 in Miami Beach at Phacilitate's Advanced Therapies Week! Contact a team member or stop by booth 313 to learn how our products and services can support your Cell or Gene Therapy. We hope to see you there!